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Introduction
Type 2 diabetes mellitus is recognized today as one of main public health problems in the world 1 . The role of type 2 diabetes mellitus as one of principal risk factors for the development of cardiovascular disease (CVD) is well investigated 2 . It's continuously rising incidence and prevalence is continually in the focus of attention and it seems to be closely related with western dietary habits, physical inactivity and ever more prevalent obesity. It is well known that, apart from genetic and environmental factors, its development and progression is also influenced by lifestyle, habits and some individual factors, as this has especially profoundly been investigated in type 2 diabetes mellitus 3 . On the other hand, it is encouraging that change of lifestyle and habits can help prevent occurrence of diabetes mellitus, in this context body weight reduction is considered as the main predictor of success in this process 4 . Several studies have shown that in persons with high risk for development of diabetes mellitus it is possible to reduce its incidence through change of lifestyle and habits, mainly with significant reduction of body weight [5] [6] [7] [8] , but, as seen in a study from India, even if no significant weight reduction is achieved 9 . European Society of Cardiology (ESC) 2007 Guidelines on management of diabetes mellitus and CVD prevention give recommendations on desired goals in patients with coronary heart disease (CHD) and diabetes mellitus [10] [11] [12] [13] 22 ]. This allowed the investigators to be able to efficiently compare results. Most of the questions had multiple answers offered in advance to acquire greater accuracy. Data was collected on patient history (personal and family history), age, sex and information on cardiovascular risk factors and discharge diagnoses. Physical examination was performed and its findings were recorded. Special focus in the questionnaire was on diabetes mellitus and dyslipidaemia. It was possible to measure the presence of these risk factors as the following laboratory data was recorded in the questionnaire: blood glucose levels with information on duration of fasting and previously diagnosed diabetes mellitus and lipidogram with values of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides.
Materials and Methods
Categories used in recording of presence of diabetes mellitus included: normal blood glucose levels, glucose intolerance and diabetes mellitus -as defined according to World Health Organization (WHO) 1999 Guidelines. Glucose concentrations lower than 6.1 mmol/L after fasting, or 7.8 mmol/L after meal were considered as normal. Glucose concentrations between 6.1 mmol/L and 7 mmol/L after fasting and between 7.8 mmol/L and 11 mmol/L after meal were considered as indicative of glucose intolerance. Values of glucose concentrations higher than 7 mmol/L after fasting, or 11.1 mmol/L after meal were considered as indicative of diabetes mellitus 12, 13, 23 . Patients with previously diagnosed diabetes mellitus were considered as having diabetes mellitus regardless of recorded glucose concentrations.
Presence of dyslipidaemia was defined according to currently valid Guidelines 10, 11, 13, 14 : in patients which were already taking statins, or as presence of LDL cholesterol concentration equal to or higher than 2.5 mmol/L in morning blood sample after period of 12 hours with no food intake, or as total cholesterol concentration equal to or higher than 4.5 mmol/L. Triglyceride concentration equal to or higher than 1.7 mmol/L and HDL cholesterol concentration less than 1 mmol/L in men and 1.2 mmol/L in women were considered as markers of increased cardiovascular risk.
Data were collected by physicians or trained personnel (nurse), coded and entered into the electronic file. Confidentiality of data was ensured in accordance with current applicable codes, declarations and other provisions. The results are shown in tables, and for quantitative variables descriptive statistics were done with appropriate measures of central tendency and variability (mean, standard deviation, medians, associated interquartile ranges). Normal distribution of quantitative variables was tested by Kolmogorov-Smirnov test, and then Table 1 shows the distribution of measured laboratory and anthropometric variables in the whole sample. Mean serum glucose levels were 7.42±3.49 mmol/L, mean serum total cholesterol levels were 5.37±1.40 mmol/L, mean serum HDL-cholesterol levels were 1.22±0.49 mmol/L, mean serum LDL-cholesterol levels were 3.30±1.14 mmol/L and mean serum triglyceride levels were 2.05±1.52 mmol/L. Comparison of these variables by sex is shown in Table 2 . Only statistically significant difference was found in serum levels of HDL-cholesterol: in women its level was higher than in men (1.28±0.45 mmol/L vs. 1.19±0 .50 mmol/L, Table 2 , p<0.001, Mann Whitney U test).
Results
Subjects were divided into 3 groups depending on measured serum glucose levels (measured in mmol/L) based on the data from the current Guidelines, taking into account whether or not they were fasting at the time when the sample was taken. Normal serum glucose levels (<6.1 fasting or <7.8 after meal) were recorded in 388 subjects (46.1%), glucose intolerance (6.1-7 fasting or 7.8-11.1 after meal) was recorded in 188 subjects (22.3%) and diabetes mellitus (>7 fasting or >11.1 after meal) was recorded in 266 subjects (31.6%). The data on serum glucose level was not available for 456 subjects. Table 3 shows comparison of measured serum glucose levels by sex. Diabetes mellitus was statistically significantly more frequent in women (35.7% vs. 30.0%), and glucose intolerance was statistically significantly more frequent in men (24.5% vs. 16.8%, p=0.040, c 2 -test).
Subjects were also divided into two groups according to the serum total cholesterol levels as recommended by the Guidelines. One group consisted of subjects with total cholesterol levels <4.5 mmol/L (330 subjects, 28.0%) and the other group consisted of subjects with total cholesterol levels ³4.5 mmol/L (847 subjects, 72.0%), while the data was not available for 121 subjects. Comparison of serum total cholesterol levels by sex showed no statistically significant differences (Table 4) . It is worth mentioning, however, that in both groups more than 70% of subjects have serum total cholesterol values above those which are recommended by the Guidelines. Subjects were also divided into two groups in relation to their serum HDL-cholesterol levels -one in which the serum HDL-cholesterol was lower than recommended levels (£1 mmol/L in men and £1.2 mmol/L in women; 464 subjects, 42.6%) and the other one in which the serum HDL-cholesterol was within the recommended range (>1 mmol/L in men and >1.2 mmol/L in women, 624 subjects, 57.4%). The data was not available for 210 subjects. Table 5 shows the comparison of serum HDL-cholesterol values in subjects by sex -there were statistically significantly more female subjects with serum HDL-cholesterol levels below those which are recommended by the Guidelines (50.2% vs. 39.6%, p=0.001, c 2 -test).
Subjects were also divided into two groups regarding their serum LDL-cholesterol levels: 293 subjects (27.7%) had those values within recommended range (<2.5 mmol/L), while in 766 subjects (72.3%) those levels were above recommended range (³2.5 mmol/L); finally, for 239 subjects the data were not available. There were no statistically significant differences between sexes (Table 6) . Finally, 565 subjects (48.5%) had serum triglyceride levels within the recommended range (<1.7 mmol/L) and 601 (51.5%) subjects had those values above the recommended range (³1.7 mmol/L), the data was not available for 132 subjects. There were no statistically significant differences between sexes (Table 7) .
Discussion
This article investigated prevalences of two well-known cardiovascular risk factors -diabetes mellitus and dyslipidaemia (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides) in the population of hospitalized Croatian CHD patients. As Croatia was one of the countries which participated in the European action on secondary prevention by intervention to reduce events (EUROASPIRE) III study performed in 22 European countries in 2006 24 , it is possible to compare this data with both Croatian and European data from that study. Furthermore, valuable data on hospitalized Croatian CHD patients was presented in Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC--CRO) V study which was performed in Croatia in 2002 and 2003 22 .
Diabetes mellitus has been shown to be one of major risk factors for the development of CHD 2 and is certainly one of largest public health problems in the world today 1 . In this study, 46.1% of subjects had normal serum glucose levels, while 31.6% had diabetes mellitus (Table 3) . Table 3 ) and interestingly, this statistically significant difference between sexes has also been observed TASPIC-CRO V study (28% of men and 34% of women had diabetes) 22 .
Assessment of the level of influence of a dyslipidaemia usually involves analysis of four main lipidogram components: total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides. Levels above those recommended by the Guidelines for total cholesterol, LDL-cholesterol and triglycerides represent a cardiovascular risk factor, while levels of HDL-cholesterol below those recommended by the Guidelines also represent an established cardiovascular risk factor [15] [16] [17] .
Unfortunately, as much as 72.0% of subjects in this study had total cholesterol levels higher than those recommended by current ESC Guidelines. This represents further increase in prevalence of this risk factor, as it's prevalence in TASPIC-CRO V study was 69% 22 and in EUROASPIRE III study considerably less (52%) 24 . Although there were no statistically significant differences between sexes, this represents a change, as in TASPIC--CRO V study the total cholesterol above recommended levels was recorded more frequently in women than in men 22 .
Levels of HDL-cholesterol which were too low according to the current Guidelines were found in 42.6% of subjects, and this was more frequently the case in women (Table 5 , 50.2% vs. 39.6%). When these data are compared to both other relevant studies, one can see that the prevalence of this risk factor is increasing. In EURO-ASPIRE III study the prevalence was 36.7% in Europe and 34.1% in Croatia 24 ; while in TASPIC-CRO V study it was 42%
22 . Contrary to results from our study, in TASPIC--CRO V study values of HDL-cholesterol lower than those recommended by the guidelines were more frequently present in men 22 .
A similar result was found when the data on prevalence of raised LDL-cholesterol was analysed -as much as 72.3% of subjects were in this group. This again represents a further increase in prevalence (in TASPIC-CRO V study the prevalence was 69%) 22 . There were no statistically significant differences between sexes in prevalence of this risk factor, however, it was, like for total cholesterol, reported in TASPIC-CRO V study that this risk factor was more frequently present in women 22 . One could speculate that the difference between sexes had been annulated by higher increase in prevalence of increased total cholesterol and LDL-cholesterol in men than in women.
More than half of the subjects (51.5%) had triglyceride levels higher than those recommended by the Guidelines, while there were no statistically significant differences between sexes. Knowing that in TASPIC--CRO V study only 37% of subjects had this risk factor 22 and in EUROASPIRE III it was present in 49.9% of subjects in Croatia (it was 51.5% on the level of European sample) 24 , one can see a clear rise in it prevalence. This is an alarming sign, as it means that we are closer than ever to the European prevalences.
Reported data on prevalences of diabetes mellitus can be somewhat reassuring (as they represent a decrease in its prevalence compared to data from 2006, but they still signal a situation which is a lot worse than in 2002 and 2003) ; the trend of rising prevalences of dyslipidaemic cardiovascular risk factors must be a cause for an alarm, furthermore as today's preventive and treatment measures in cardiology, both primary and secondary, are strongly focused on dyslipidaemias. One would expect that with ever-increasing use of drugs and other interventions, those prevalences would show a stable decreasing trend. However, our data suggests this is still not the case. One can only speculate what those prevalences would be like if our society was not combating these risk factors at all.
